PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24899384 ↗2014No effect reported

Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity.

RatChemical/toxinWistar-HanMaleOral by gavage10 mg/kg dailyPretreatment for 7 days before isoprenaline

Model: Acute myocardial toxicity induced by subcutaneous isoprenaline (isoproterenol) 100 mg/kg

Quercetin did not protect against isoprenaline-induced falls in stroke volume, troponin T release, QRS-T junction elevation or histological damage; the only positive effect was normalisation of raised left ventricular end-diastolic pressure.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.